Success in Reaching 15 by 15 Shows That We Can End the AIDS Epidemic
New UNAIDS Report Describes How the World Achieved the Global Treatment Target
July 19, 2015
Vancouver, Canada -- Following up on United Nations Secretary-General Ban Ki-moon's announcement on 14 July that the world had reached the target of providing antiretroviral therapy to 15 million people living with HIV, UNAIDS is releasing a new report that describes the factors that helped the world achieve the '15 by 15' target. Launched at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada, 15 by 15: A global target achieved describes how diverse stakeholders and constituencies united in a common global undertaking to save lives.
Lessons learned in the successful global push to provide antiretroviral therapy to 15 million people by 2015 provide a roadmap for ending the AIDS epidemic as a public health threat. As a central component of the effort to end the epidemic, the world has embraced a new target for antiretroviral therapy. By 2020: (a) 90% of all people living with HIV will know their HIV status, (b) 90% of all people with an HIV diagnosis will receive sustained antiretroviral therapy, and (c) 90% of all people receiving antiretroviral therapy will achieve viral suppression.
"This is the first time in the history of global health that we have reached a treatment target by the deadline," said UNAIDS Executive Director, Michel Sidibé. "If anyone doubted this in the past, it is now clearer than ever that bold, ambitious targets drive global health progress. We now need to take what we have learned in the '15 by 15' movement and do what it takes to end the AIDS epidemic once and for all."
Ingredients for Success in the '15 by 15' Movement
The '15 by 15' target was adopted at a United Nations High Level Meeting in 2011, as part of the Political Declaration on HIV and AIDS: Intensifying Our Efforts to Eliminate HIV and AIDS. The new UNAIDS report focuses on the years 2011-2015, describing what happened to make achievement of the goal possible. The report's key findings include the following:
Leveraging the '15 to 15' Success to Achieve the 90-90-90 Target
The essential lessons from '15 by 15' are immediately valuable for global efforts to lay the foundation to end the AIDS epidemic as a public health threat by 2030. Achievement of the 90-90-90 target, along with ambitious new targets for primary HIV prevention and non-discrimination, would reduce the number of new HIV infections by 89% by 2030 and the number of AIDS-related deaths by 81%.
"We have no time to waste, as the next five years represent a brief window of opportunity," said Mr Sidibé. "We need to put the lessons we have learned from '15 by 15' to use to 'fast-track' the AIDS response and achieve the 90-90-90 target."
The new report outlines emerging challenges that the AIDS response must face as it works to achieve the 90-90-90 target. These include uncertainties regarding the financial sustainability of HIV treatment scale-up and market dynamics that potentially imperil the future affordability of the second- and third-line antiretroviral regimens that more and more people living with HIV will need.
To meet these challenges, the new report outlines strategic actions that the world needs to take. Political commitment to end the epidemic will be essential, as will concerted efforts to engage and empower communities to deliver HIV testing and treatment services. New investments will be needed, especially as spending towards ambitious new prevention, treatment and non-discrimination targets yield US$ 17 in savings for every US$ 1 invested. Immediate actions are needed to ensure a robust, uninterrupted supply of affordable medicines, including building local manufacturing capacity in sub-Saharan Africa. In addition, structural barriers to service access, including those caused by punitive laws and policies, must be removed.
UNAIDS, Lancet: Take Accelerated Action on HIV Treatment Access, Research and Development, and Address Epidemic Drivers, or Risk Rebound
This article was provided by UNAIDS. Visit UNAIDS' website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.